1-2 of 2
John R. Mackey, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Nonclinical Efficacy and Toxicity and Selection of a Safe Clinical Starting Dose for an NMT Inhibitor in Development for Hematological Malignancies

Michael J. Weickert, PhD, John Dillberger, DVM, PhD, Caren Brown, Francis Phaneuf, John R. Mackey, MD, Randeep Sangha, MD, Luc G. Berthiaume, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-141910
Published: 2020
Journal Articles

N-Myristoyltransferase 2 (NMT2) Protein Levels Predict Survival in Acute Myeloid Leukemia (AML): A Novel Prognostic Biomarker

Ryan J Stubbins, MDMSc, Zoulika Zak, Aishwarya Iyer, Megan Yap, Krista Vincent, Lynne M Postovit, MD, John R Mackey, MD, Artur J Szkotak, MD PhD, Lalit Saini, MD, Luc G Berthiaume, PhD, Joseph M. Brandwein, MD FRCPC
Journal: Blood
Blood (2017) 130 (Supplement 1): 3914.
https://doi.org/10.1182/blood.V130.Suppl_1.3914.3914
Published: 2017